DD280765A5 - Verfahren zur herstellung neuer verbindungen der formel ii mit nootroper wirkung - Google Patents
Verfahren zur herstellung neuer verbindungen der formel ii mit nootroper wirkung Download PDFInfo
- Publication number
- DD280765A5 DD280765A5 DD87301118A DD30111887A DD280765A5 DD 280765 A5 DD280765 A5 DD 280765A5 DD 87301118 A DD87301118 A DD 87301118A DD 30111887 A DD30111887 A DD 30111887A DD 280765 A5 DD280765 A5 DD 280765A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- alkyl
- atoms
- aryl
- substituted
- under
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19863610391 DE3610391A1 (de) | 1986-03-27 | 1986-03-27 | Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen |
Publications (1)
Publication Number | Publication Date |
---|---|
DD280765A5 true DD280765A5 (de) | 1990-07-18 |
Family
ID=6297417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD87301118A DD280765A5 (de) | 1986-03-27 | 1987-03-25 | Verfahren zur herstellung neuer verbindungen der formel ii mit nootroper wirkung |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0243645B1 (no) |
JP (1) | JPS62240698A (no) |
KR (1) | KR870008841A (no) |
CN (1) | CN1031267C (no) |
AT (1) | ATE102954T1 (no) |
AU (1) | AU621278B2 (no) |
CA (1) | CA1341064C (no) |
CS (2) | CS212687A3 (no) |
DD (1) | DD280765A5 (no) |
DE (2) | DE3610391A1 (no) |
DK (1) | DK172221B1 (no) |
EG (1) | EG18175A (no) |
ES (1) | ES2061447T3 (no) |
FI (1) | FI91876C (no) |
HU (2) | HU202118B (no) |
IE (1) | IE62456B1 (no) |
MA (1) | MA20919A1 (no) |
NO (1) | NO178546C (no) |
NZ (1) | NZ219764A (no) |
OA (1) | OA08506A (no) |
PH (1) | PH27210A (no) |
PT (1) | PT84564B (no) |
RU (1) | RU1836335C (no) |
TN (1) | TNSN87045A1 (no) |
ZA (1) | ZA872230B (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5231084A (en) * | 1986-03-27 | 1993-07-27 | Hoechst Aktiengesellschaft | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons |
US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
AU612137B2 (en) * | 1987-04-27 | 1991-07-04 | E.R. Squibb & Sons, Inc. | Method for inhibiting loss of cognitive functions employing an ace inhibitor |
DE3731085A1 (de) * | 1987-09-16 | 1989-04-06 | Hoechst Ag | Neue aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
DE3739690A1 (de) * | 1987-11-24 | 1989-06-08 | Hoechst Ag | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen |
DE3801587A1 (de) * | 1988-01-21 | 1989-08-03 | Hoechst Ag | Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
EP0331609A3 (de) * | 1988-01-27 | 1992-07-01 | Hoechst Aktiengesellschaft | Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung |
DE3803225A1 (de) * | 1988-02-04 | 1989-08-17 | Hoechst Ag | Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung |
JPH01275529A (ja) * | 1988-03-21 | 1989-11-06 | E R Squibb & Sons Inc | 晩発性運動障害の抑制治療剤 |
US5037821A (en) * | 1988-06-01 | 1991-08-06 | E. R. Squibb & Sons, Inc. | Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor |
US5093129A (en) * | 1989-01-30 | 1992-03-03 | E. R. Squibb & Sons, Inc. | Method for treating addiction to a drug of abuse employing an ace inhibitor |
US5032578A (en) * | 1990-09-17 | 1991-07-16 | E. R. Squibb & Sons, Inc. | Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
AU2002245692A1 (en) * | 2001-03-15 | 2002-10-03 | David Pharmaceuticals | Methods for restoring cognitive function following systemic stress |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0050800B2 (en) * | 1980-10-23 | 1995-06-07 | Schering Corporation | Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
DE3300774A1 (de) * | 1983-01-12 | 1984-07-12 | Hoechst Ag, 6230 Frankfurt | Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung |
-
1986
- 1986-03-27 DE DE19863610391 patent/DE3610391A1/de not_active Withdrawn
-
1987
- 1987-03-18 EP EP87103938A patent/EP0243645B1/de not_active Expired - Lifetime
- 1987-03-18 DE DE87103938T patent/DE3789330D1/de not_active Expired - Lifetime
- 1987-03-18 AT AT87103938T patent/ATE102954T1/de not_active IP Right Cessation
- 1987-03-18 ES ES87103938T patent/ES2061447T3/es not_active Expired - Lifetime
- 1987-03-25 FI FI871304A patent/FI91876C/fi not_active IP Right Cessation
- 1987-03-25 HU HU896609A patent/HU202118B/hu unknown
- 1987-03-25 MA MA21159A patent/MA20919A1/fr unknown
- 1987-03-25 NZ NZ219764A patent/NZ219764A/en unknown
- 1987-03-25 DD DD87301118A patent/DD280765A5/de not_active IP Right Cessation
- 1987-03-25 PH PH35073A patent/PH27210A/en unknown
- 1987-03-25 EG EG18087A patent/EG18175A/xx active
- 1987-03-25 HU HU871308A patent/HU203117B/hu unknown
- 1987-03-26 KR KR870002775A patent/KR870008841A/ko not_active Application Discontinuation
- 1987-03-26 AU AU70649/87A patent/AU621278B2/en not_active Expired
- 1987-03-26 RU SU874202302A patent/RU1836335C/ru active
- 1987-03-26 PT PT84564A patent/PT84564B/pt unknown
- 1987-03-26 CA CA000533092A patent/CA1341064C/en not_active Expired - Lifetime
- 1987-03-26 NO NO871282A patent/NO178546C/no unknown
- 1987-03-26 JP JP62070541A patent/JPS62240698A/ja active Pending
- 1987-03-26 DK DK153587A patent/DK172221B1/da not_active IP Right Cessation
- 1987-03-26 ZA ZA872230A patent/ZA872230B/xx unknown
- 1987-03-26 IE IE78487A patent/IE62456B1/en not_active IP Right Cessation
- 1987-03-27 OA OA59095A patent/OA08506A/xx unknown
- 1987-03-27 CN CN87102304A patent/CN1031267C/zh not_active Expired - Lifetime
- 1987-03-27 CS CS872126A patent/CS212687A3/cs unknown
- 1987-03-27 CS CS896519A patent/CS651989A3/cs not_active IP Right Cessation
- 1987-03-27 TN TNTNSN87045A patent/TNSN87045A1/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH10182456A (ja) | 高血圧治療用医薬組成物 | |
DD280765A5 (de) | Verfahren zur herstellung neuer verbindungen der formel ii mit nootroper wirkung | |
EP0219782B1 (de) | Verwendung von Angiotensin-Converting-Enzym-Inhibitoren zur Behandlung von Atherosklerose, Thrombose und der peripheren Gefässkrankheit | |
EP0417473B1 (de) | Verfahren zur Behandlung der cardialen sowie der vasculären Hypertrophie und Hyperplasie | |
DE3830096A1 (de) | Piperazindione mit psychotroper wirkung | |
US5231084A (en) | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons | |
EP0158927A2 (de) | Verfahren zur Behandlung der Herzinsuffizienz | |
DE3801587A1 (de) | Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung | |
DE3803225A1 (de) | Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung | |
US5114962A (en) | New amino acid esters, a process for their preparation, medicaments containing them, and the use thereof | |
EP0488059A2 (de) | Verwendung einer Kombination aus Angiotensin-Converting-Enzyme-Hemmer und Calciumantagonist zur Behandlung einer Proteinurie | |
EP0331609A2 (de) | Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung | |
DE3410732A1 (de) | Methode zur behandlung des glaukoms | |
DE3839127A1 (de) | Pyrrolidon-2-carbonsaeure-derivate mit psychotroper wirkung | |
DE3532035A1 (de) | Neue n-alkylierte tripeptide, verfahren zu ihrer herstellung, sie enthaltende medikamente und deren verwendung | |
DE3912668A1 (de) | Aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung | |
EP0215357A2 (de) | Pharmazeutische Zubereitung zur Behandlung des Bluthochdrucks | |
KR900003321B1 (ko) | 인식보조작용이 있는 화합물, 이를 함유하는 제제 및 인식 기능 장애를 치료하고 예방하는데 있어서 이의 용도 | |
DE3901291A1 (de) | Verbindungen mit psychotroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe von stoerungen des zentralen nervensystems | |
EP0670330A1 (de) | Langkettige Alkylamide von Aminosäuren und Peptiden mit antiproliferativen und entzündungshemmenden Eigenschaften |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |